Health Care/Hospital

The U.S. Fish and Wildlife Service Rejects Petition to List Long-Tailed Macaques Under the Endangered Species Act

WASHINGTON, Oct. 8, 2024 /PRNewswire/ -- On October 7, 2024, the U.S. Fish and Wildlife Service ("USFWS" or "the Service") declined to accept a petition filed by People for the Ethical Treatment of Animals (PETA) and other advocacy groups to list long-tailed macaque ("LTM") monkeys (Macaca fascic...

2024-10-08 03:31 1373

GBI Biomanufacturing and Allterum Therapeutics Announce Strategic Collaboration to Manufacture Therapeutic Antibody for Clinical Trials

PLANTATION, Florida and HOUSTON, Texas, Oct. 8, 2024 /PRNewswire/ -- GBI Biomanufacturing, a leading Contract Development and Manufacturing Organization (CDMO), andAllterum Therapeutics, a Fannin-Founded Company, are pleased to announce a manufacturing partnership to advance Allterum's lead candi...

2024-10-08 00:00 1218

HoneyNaps actively supplies "AI solutions" to U.S. medical institutions

* Rapid commercialization and delivery to the U.S. after FDA approval * Aiming to achieve a 10% market share within three years * Aggressive sales and expansion of distribution network through U.S. subsidiaries BOSTON, Oct. 7, 2024 /PRNewswire/ -- HoneyNaps announced on September 9th that it...

2024-10-07 21:00 953

Prenetics Announces Second Quarter 2024 Financial Results

Cost Optimization Boosted Gross Margin by 21.7% YoY in H1 2024 Enters U.S. Health Market in October with IM8, a New Health and Wellness brand Re-affirms Revenue Target to Exceed US$33 million for FY 2024 CHARLOTTE, N.C., Oct. 7, 2024 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE) ("Preneti...

2024-10-07 20:30 3345

Concordia Shanghai's Early Childhood Division Ranked Among Top 5 in China

SHANGHAI, Oct. 7, 2024 /PRNewswire/ -- Concordia Shanghai's Early Childhood (EC) Division has earned a top spot in the KingLead China International Kindergarten Ranking, placing No. 1 inShanghai and No. 4 in China. This recognition reflects Concordia's continued commitment to excellence and holi...

2024-10-07 18:30 1671

NTC Launches Imperial, the new eye drops product line on THE PATIENT'S SIDE

MILAN, Oct. 7, 2024 /PRNewswire/ -- NTC, an international pharmaceutical company headquartered inMilan, Italy, announced today to have embraced a strategic partnership with Silgan Dispensing Systems, a global leading supplier of dispensing solutions in healthcare to commercialize a set of new NTC...

2024-10-07 18:00 1032

Mérieux NutriSciences Enters Agreement to Acquire Worldwide Food Testing Business of Bureau Veritas

* The transaction will create a business with $1bn in revenue, significantly reinforcing Mérieux NutriSciences' position as a global leader in food testing, inspection, and certification (TIC). * It expands Mérieux NutriSciences' geographic footprint, doubling its presence inAsia Pacific and ...

2024-10-07 14:25 1695

Antengene to Present Results from Three Programs at the 2024 SITC Annual Meeting

SHANGHAI and HONG KONG, Oct. 5, 2024 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cance...

2024-10-07 13:14 1788

/C O R R E C T I O N -- APAC Liver Disease Alliance/

In the news release, APAC LIVER DISEASE ALLIANCE HOSTS "HEP-FREE: ELIMINATING ASIA'S SILENT PUBLIC HEALTH THREAT BY 2030" SUMMIT IN BANGKOK ON 1 OCTOBER 2024 , issued02-Oct-2024 by APAC Liver Disease Alliance over PR Newswire, we are advised by the company that the photo caption, should read "Kamo...

2024-10-07 11:34 3180

Alpha Asia Aesthetics: an Instagram-Worthy Aesthetic Clinic Launched in Partnership with Entrepreneur Investor Ivan Lee

SINGAPORE, Oct. 7, 2024 /PRNewswire/ -- Influencer doctor Dr Jeanel Goh and the famed founder of Thai Express, MrIvan Lee, have come together to leave their mark onSingapore's Aesthetic Medicine scene with their brainchild: Alpha Asia Aesthetics . Leveraging on Dr...

2024-10-07 10:10 1750

Medinol Announces Successful First-in-Human Implantation of ChampioNIR Drug-Eluting Peripheral Stent System in Australia

TEL AVIV, Israel, Oct. 7, 2024 /PRNewswire/ -- Medinol Ltd. is pleased to announce the successful First-in-Human (FIH) implantation of the ChampioNIR Drug-Eluting Peripheral Stent by DrsGerard S.Goh and Thodur Vasudevan of the Alfred Hospital inMelbourne Australia, introducing a revolutionary adv...

2024-10-07 06:00 1308

PROMISING CELL THERAPY OFFERS HOPE FOR RELAPSED OR REFRACTORY T-CELL LEUKAEMIA

Fratricide-resistant CD7 CAR-T therapy by NUS proves effective in treating relapsed or refractory T-cell leukaemia SINGAPORE, Oct. 5, 2024 /PRNewswire/ -- A new cell therapy, targeting CD7 on leukaemia cells, gives a potentially effective treatment for patients with T-cell acute lymphoblastic le...

2024-10-05 06:00 7176

Cyient DLM Expands Global Footprint with Strategic Acquisition of US-Based EMS Manufacturer

HYDERABAD, India, Oct. 4, 2024 /PRNewswire/ -- Cyient DLM, a leading integrated electronics manufacturing company, announced today its acquisition of Altek Electronics, a prominent EMS (Electronic Manufacturing Services) company based inthe United States. This strategic move marks a significant m...

2024-10-04 21:00 4557

TiumBio Announces First Patient Dosed in Phase 2 Clinical Trial of Oral Immuno-Oncology Drug TU2218

* TU2218 is a potentially first-in-class dual inhibitor targeting transforming growth factor beta receptor 1 (TGFR1) and vascular endothelial growth factor receptor 2 (VEGFR2) * The first patient with head and neck squamous cell carcinoma was dosed in the Phase 2a clinical trial of TU2218 *...

2024-10-04 20:00 1650

Clarivate in partnership with Abiquifi Announces Annual Summit LATAM Agenda

Top industry leaders to explore AI, data, strategic partnerships, and innovation opportunities inLatin America at premier Life Sciences event LONDON, Oct. 4, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) a leading global provider of transformative intelligence, today announced the full agenda ...

2024-10-04 15:00 1793

Sirnaomics Has Been Subscribed for 17,527,696 Subscription Shares, New Capital Injection to Promote Business Growth and Development

HONG KONG, GERMANTOWN, Md., and SUZHOU, China,, Oct. 4, 2024 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", together with its subsidiaries, the "Group" or " Sirnaomics"; stock code: 2257.HK), a leading biopharmaceutical company engaged in the discovery and development of advanced RNAi therapeutic...

2024-10-04 13:03 5537

ABL Bio Announces Clinical Collaboration to Evaluate ABL103 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Solid Tumors

- MSD will supply KEYTRUDA to be evaluated in combination with ABL Bio's ABL103 in a Phase1b/2 clinical trial SEONGNAM, South Korea, Oct. 4, 2024 /PRNewswire/ -- ABL Bio (CEO Sang Hoon Lee ), a company specializing in bispecific antibodies, today announced that it has entered into a clinical tria...

2024-10-04 12:40 2360

Xinhua Silk Road: Ex-champ Bruno Hasulyo starts new career to bolster SUP in eastern China metropolis

BEIJING, Oct. 4, 2024 /PRNewswire/ -- Born in Hungary, Bruno Hasulyo is not just a professional athlete but also an adventurer at heart and a visionary entrepreneur. His life journey has been driven by a singular goal -- becoming an iconic figure in the world of stand-up paddling (SUP) and usher...

2024-10-04 12:30 7506

Siriraj Enhances Diagnostic Capabilities, a Crucial Factor for Medical Care

BANGKOK, Oct. 4, 2024 /PRNewswire/ -- Siriraj Hospital excels in maintaining its high standards for every service, including diagnostics through the integration of cutting-edge technology into its medical services, furthering its mission to become a global leader in healthcare. The hospital is fo...

2024-10-04 11:18 2218

Agilent and National University of Singapore Launch Center of Excellence in Cell Metabolism to Improve Population Health

Center will enable targeted and untargeted metabolic profiling for population-based large-scale cohorts across translational research SINGAPORE, Oct. 4, 2024 /PRNewswire/ -- Agilent Technologies Inc.

2024-10-04 09:00 2674
1 ... 24252627282930 ... 847